TY - JOUR
KW - Anxiety/diagnosis/etiology/therapy
KW - Depression/diagnosis/etiology/therapy
KW - Humans
KW - Opioid-Related Disorders/diagnosis/drug therapy/psychology
KW - Psychotherapy/methods
KW - Psychotropic Drugs/classification/pharmacology
KW - Treatment Outcome
AU - A. N. Hassan
AU - A. S. Howe
AU - A. V. Samokhvalov
AU - B. Le Foll
AU - T. P. George
A1 - 
AD - Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Department of Family and Community Medicine, Pharmacology and Toxicology, Psychiatry, Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.; Campbell Family Mental Health Research Institute, CAMH, Toronto, Ontario, Canada.; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Toronto, Ontario, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
BT - The American journal on addictions
C5 - Opioids & Substance Use
CP - 6
CY - England
DO - 10.1111/ajad.12581
IS - 6
JF - The American journal on addictions
M1 - Journal Article
PB - American Academy of Addiction Psychiatry
PP - England
PY - 2017
SN - 1521-0391; 1055-0496
SP - 551
EP - 563
EP - 
T1 - Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta-analysis
T2 - The American journal on addictions
TI - Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta-analysis
U1 - Opioids & Substance Use
U2 - 28675762
U3 - 10.1111/ajad.12581
VL - 26
VO - 1521-0391; 1055-0496
Y1 - 2017
Y2 - Sep
ER -